Since MDM2 played a crucial role in regulating the stability of p53 and served as an excellent substrate for AKT, we speculate that CTD is likely to inhibit cell proliferation via the AKT-MDM2-p53 pathway in CRC. Here, MDM2 is linked to colorectal carcinoma.